acute- and post-myocardial infarction, and congestive heart failure. However, β blockers do not all share the same clinical outcomes with respect to efficacy or safety in many of these conditions.

The findings hint at why the ABYSS trial failed to show it was safe to stop beta-blockers after an MI in stable patients.

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms ...

Beta blockers are a heart medication, but some docs prescribe it off-label to help with situational anxiety. Click here for ...

Aficamten was associated with improved peak oxygen uptake and a tolerable safety profile vs. metoprolol, a beta-blocker, in ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

The research, published in the journal Hypertension, found that women with high blood pressure who take beta-blockers may ...

Broken heart syndrome sounds like something out of a romance novel. But it's a bona fide medical condition that feels like a ...

EMJ spoke with Srihari S. Naidu, who shared insights into his pioneering work in alcohol septal ablation, his contributions ...

On Thursday, the startup unveiled $65 million to begin human testing with a lead therapeutic candidate that could demonstrate this approach in a type of heart failure. “We need to think about ...

Learn the warning signs that differentiate harmless coughs from those requiring medical attention, including timeline ...

The Get With the Guidelines-Heart Failure program was developed in 2005 with the goal ... with a higher overall risk profile were less likely to receive treatment with beta blockers and ...